Mass Spectrometry Peptide Fragmentation

Mass spectrometry peptide fragmentation is a key technique in proteomics research. Its core principle involves selectively fragmenting peptides using a mass spectrometer to obtain primary structural information. The peptide fragmentation process typically includes three steps: ionization, selection, and fragmentation. During the ionization stage, peptide molecules are converted into charged ions, facilitating mass spectrometric analysis. Subsequently, the mass spectrometer's mass selection function is used to choose target peptide ions for further analysis. Finally, in the fragmentation stage, the selected peptide ions are broken down into smaller fragment ions through techniques such as collision-induced dissociation (CID), high-energy collision dissociation (HCD), or electron transfer dissociation (ETD). By accurately measuring the mass-to-charge ratio (m/z) of these fragment ions, the amino acid sequence information of the peptides can be deduced. Mass spectrometry peptide fragmentation is widely used in protein identification, modification analysis, structural elucidation, and the analysis of complex biological samples. In protein identification, the sequence information obtained from mass spectrometric analysis of peptide fragmentation can be compared with known sequences in databases, allowing for the identification of unknown proteins. In protein modification analysis, this technique can identify and locate post-translational modifications such as phosphorylation and glycosylation, which play important roles in cell signaling, functional regulation, and disease occurrence. Additionally, it can provide protein structural information, aiding in the understanding of protein function and its interactions with ligands or other proteins.

 

The application of mass spectrometry peptide fragmentation in proteomics research not only improves the accuracy and sensitivity of protein analysis but also accelerates progress in the fields of biomedicine and biotechnology. Peptide fragmentation mass spectrometry analysis reveals the complex roles of proteins in cellular biology by providing detailed analysis of peptides, helping researchers better understand the relationship between proteins and diseases. For example, in cancer research, peptide fragmentation mass spectrometry can identify biomarker proteins associated with carcinogenesis, which is significant for targeted therapy and early diagnosis.

 

In the operation of mass spectrometry peptide fragmentation, various factors need to be considered to ensure the accuracy and reliability of the results. Selecting the appropriate fragmentation method is crucial. CID and HCD are usually used for higher resolution mass spectrometric analysis, while ETD is suitable for analyzing highly charged peptides. During the fragmentation process, sample preparation and purification are equally important, as sample purity and concentration directly affect the sensitivity and accuracy of mass spectrometric analysis. Advances in modern mass spectrometers have broadened their application range, extending beyond basic scientific research to clinical diagnostics and biopharmaceuticals.

 

Bio-Techne has accumulated rich experience in protein mass spectrometry identification, committed to providing high-quality mass spectrometry analysis services to customers. Whether in protein identification or modification analysis, we are capable of delivering accurate and reliable results. Our services are not limited to experimental operations but also include data analysis and result interpretation, ensuring that customers receive a complete solution.

 

Bio-Techne - Characterization of Biologics, a Leading Service Provider in Multi-Omics Mass Spectrometry Detection

 

Related Services: